Key Regulatory Considerations for Moving Your Cell Therapy Research to the Clinic

Regulatory considerations for Cell and Gene Therapies - Jim DeKloeПодробнее

CMC challenges in cell and gene therapy manufacturingПодробнее

Webinar: Clinical Trials - Moving Stem Cell based Therapies to the Clinic, IntroductionПодробнее

Catapult Your Cell Therapy Research Into the Clinic: Beyond Immuno-OncologyПодробнее

A-Cell: Regulatory ConsiderationsПодробнее

CTS Essential 8 Medium: Transition your PSC research to the clinic with confidenceПодробнее

CTS Essential 8 Medium: Transition your PSC research to the clinic with confidenceПодробнее

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients w...Подробнее

Companion Diagnostic Approaches in the Development of Cell and Gene TherapiesПодробнее

Regulatory challenges in automating CGT manufacturingПодробнее

Manufacturing Considerations in Cell Therapy Development | Anne Kantardjieff, Ph.D.Подробнее

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene TherapyПодробнее

Overcoming Manufacturing Challenges for Gene-Enabled Cell TherapiesПодробнее

Current and future state of T cell therapy manufacturing - Closing, automating and preparingПодробнее

Webinar: Discovery to Clinic - CRISPR-based Therapies and DiagnosticsПодробнее

Regulatory and legal frameworks for offering stem cell therapies in MexicoПодробнее

Enterprise Solutions for Cell Therapy: OverviewПодробнее

Regulatory qualification for the EBMT patient registry for CAR T-cell therapyПодробнее

Understanding US FDA Regulatory Responsibilities for Cell Therapy CompaniesПодробнее